Related Experiment Video
Updated: May 7, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
C3 nephritic factor associated with C3 glomerulopathy in children
Camille Nicolas1, Vincent Vuiblet, Veronique Baudouin
1Department of Pediatrics, Nephrology unit, CHU de Reims, Reims, France.
Insights
C3 glomerulopathy (C3G) in children associated with C3 nephritic factor (C3NeF) shows varied symptoms and outcomes. Anti-proteinuric treatments may help manage the condition, but immunosuppressive therapy effectiveness is uncertain.
Area of Science:
- Nephrology
- Complement System Biology
- Pediatric Nephrology
Background:
- C3 glomerulopathy (C3G) involves abnormal complement alternative pathway activity and C3 deposition in kidneys.
- C3 nephritic factor (C3NeF) is present in half of C3G patients, encompassing dense deposit disease (DDD) and C3 glomerulonephritis (C3GN).
Purpose of the Study:
- To investigate pediatric cases of C3G specifically associated with C3NeF.
- To analyze the clinical presentation, renal histology, and outcomes in children with C3NeF-associated C3G.
Main Methods:
- Retrospective review of 18 pediatric C3G cases with C3NeF.
- Analysis of clinical data, kidney biopsy findings (C3GN, DDD), and complement levels (C3, sC5b9).
- Exclusion of patients with identified mutations in CFH, CFI, and MCP genes.
Main Results:
- Presentations included recurrent hematuria, nephrotic syndrome, acute kidney injury, and post-infectious glomerulonephritis.
- Low C3 levels were observed in 12 patients; kidney biopsies revealed C3GN (10) and DDD (8).
- Relapse occurred in 7 patients; long-term outcomes included dialysis (2), persistent proteinuria (11), and variable treatment responses.
Conclusions:
- C3NeF-associated C3G in children presents heterogeneously with diverse clinical courses.
- Anti-proteinuric agents show potential for disease control, even post-nephrotic syndrome.
- The efficacy of immunosuppressive treatments like steroids requires further investigation.
Background:
C3 glomerulopathy (C3G) is characterized by predominant C3 deposits in glomeruli and dysregulation of the alternative pathway of complement. Half of C3G patients have a C3 nephritic factor (C3NeF). C3G incorporated entities with a range of features on microscopy including dense deposit diseases (DDD) and C3 glomerulonephritis (C3GN). The aim of this work was to study children cases of C3G associated with C3NeF.
Methods:
We reviewed 18 cases of C3G with a childhood onset associated with C3NeF without identified mutations in CFH, CFI, and MCP genes.
Results:
Clinical histories started with recurrent hematuria for seven patients, nephrotic syndrome for four, acute post-infectious glomerulonephritis for three and acute renal failure for four. Twelve patients had a low C3 at first investigation. Kidney biopsy showed ten C3GN and eight DDD. Twenty-three percent of the patients tested presented elevated sC5b9. Seven patients relapsed 3 to 6 years after the onset. At the end of follow-up, two patients were under dialysis, 11 had a persistent proteinuria, five had none; four patients did not follow any treatment. Steroids were first used in 80 % of cases.
Conclusions:
C3NeF associated C3G has a heterogeneous presentation and outcome. Anti-proteinuric agents may control the disease during follow-up, even after nephrotic syndrome at the onset. The efficiency of immunosuppressive therapy remains questionable.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Cytomegalovirus Disease
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...

